002332 Zhejiang Xianju Pharmaceutical
- 12.64
- +0.05+0.40%
Zhejiang Xianju Pharmaceutical News
Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20241028
Xianju Pharmaceutical: Report for the third quarter of 2024
Xianju Pharmaceutical: Announcement of Board Resolutions
Xianju Pharmaceutical: Announcement of Supervisory Committee Resolutions
Xianju Pharmaceutical: Notice on acceptance of the application for registration of betahistine mesylate tablets
Xianju Pharmaceutical: Announcement on the consistency evaluation of Neostigmine methosulfate injection
Xianju Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Xianju Pharmaceutical
Xianju Pharmaceutical: Legal Opinion of Shanghai AllBright Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Xianju Pharmaceutical
Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240904
Xianju Pharmaceutical: 002332 Xianju Pharmaceutical Investor Relations Management Information 20240828
Xianju Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Xianju Pharmaceutical: 2024 Semi-Annual Financial Report
Xianju Pharmaceutical: 2024 Semi-Annual Report Summary
Xianju Pharmaceutical: Announcement on matters relating to changing and abandoning shareholding companies\' capital increase and share priority pledge payment rights
Xianju Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement
Xianju Pharmaceutical: Announcement on renewing the Company\'s 2024 Audit Institution
Xianju Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Xianju Pharmaceutical: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Xianju Pharmaceutical: Announcement on the intention of the wholly-owned subsidiary Hangzhou Nengcuaixin Medical Technology Co., Ltd. to absorb and merge the wholly-owned subsidiary Hangzhou Ziming Gene Technology Co., Ltd.
Xianju Pharmaceutical: Semi-Annual Report Board Resolution Announcement
Analysis
Price Target
No Data
No Data